[Vutrisiran (hereditary transthyretin amyloidosis) - Benefit assessment according to § 35a SGB V]
Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen
Record ID 32018004361
German
Original Title:
Vutrisiran (hereditaere Transthyretin-Amyloidose mit Polyneuropathie)
Details
Project Status:
Completed
URL for project:
https://www.iqwig.de/projekte/a22-114.html
Year Published:
2023
URL for published report:
https://www.iqwig.de/download/a22-114_vutrisiran_nutzenbewertung-35a-sgb-v_v1-0.pdf
English language abstract:
There is no English language summary available
Publication Type:
Full HTA
Country:
Germany
MeSH Terms
- Amyloid Neuropathies, Familial
- Amyloid Neuropathies
- Polyneuropathies
- RNA, Small Interfering
- Prealbumin
Keywords
- Vutrisiran
- Amyloid Neuropathies
- Benefit Assessment
- NCT03759379
Contact
Organisation Name:
Institute for Quality and Efficiency in Health Care (IQWiG)
Contact Address:
IQWiG, Siegburger Str. 237, 50679 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851
Contact Email:
berichte@iqwig.de
Copyright:
Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.